Scenarios that move DRUG

Bright Minds Biosciences Inc. - common stock

Scenarios that move DRUG: 1 analysis, 0 positive, 1 negative.

  1. · Xenon files epilepsy NDA as depression study setback weighs — ▼ · impact -20 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing